维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Rivory LP"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Clinical pharmacokinetics of docetaxel显示文摘	Clarke SJ Rivory LP	1999	Clinical Pharmacokinetics1999，36，12：	1
2	Hepatic disposition of neurotoxins and pesticides显示文摘	Yang MC McLean AJ Rivory LP	2000	Pharmacol Toxicol2000，87，：	1
3	Solid-Phase Extraction ( SPE ) Techniques for Sample Preparation in Clinical and Pharmaceutical Analysis: A Brief Overview 显示文摘	Li KM Rivory LP Clarke SJ	2006	Curr Pharma Anal2006，2，2：	1
4	The erythromycin breath test for the prediction of drug clearance显示文摘	Rivory LP Slaviero KA Hoskins JM	2001	Clin Pharmacokinet2001，40，3：	1
5	Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chro- matography显示文摘	RIVORY LP CLARKE SJ BOYER M	2001	J Chromatogr B Biomed Sci Appl2001，765，2：	1
6	Clinical and preclinical pharmacokinetics of raltitrexed显示文摘	Clarke S J Beale PJ Rivory LP		0，，06：	1
7	Trace analysis of SN-38 in human plasma by high-performance liquid chromatography显示文摘	RIVORY LP FINDLAY M CLARKE S	1998	J Chromatogr B1998，714，2：	1
8	Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog 显示文摘	Pond SM Rivory LP Hampson EC	1993	J Toxieol Clin Toxicol1993，31，2：	1
9	Kinetics of toxic doses ff paraquat and the effects of hemoperfusion in the dog 显示文摘	?ond SM Rivory LP Hampson EC	1993	J l''oxicol Clin Toxicol1993，31，2：	1
10	Oinical pharmacokinetics of docetaxe显示文摘	Clarke S J Rivory LP	1999	Clin Pharmacokinet1999，36，：	1
11	Factors affecting cytochrome P450 3A aclivity in cancer patients显示文摘	Baker SD van Schaik RH Rivory LP et at	2004	Clin Cancer Res2004，10，24：	1
12	Identification and kinetics of glucuronide metabolite of SN-38 in human plasma after administration of the camptotheein derivative irinotecan显示文摘	Rivory LP Robert J	1995	Cancer Chemother Pharmacol1995，36，2：	1
13	Kinetics of the in vivo interconversion of the carboxylate and lactone forms of irinoteean(CPT-11) and its metabolite SN-38 in patients显示文摘	Rivory LP Chatelut E Canal P	1994	Cancer Res1994，54，24：	1
14	Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10- hydroxycamptotheein (SN-38), by human liver carboxylesterase显示文摘	Rivory LP Bowles MR Robert J	1996	Biochem Pharmacol1996，52，7：	1
15	Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response 显示文摘	Rivory LP Slaviero KA Clarke SJ	2002	Br J Cancer2002，87，3：	1
16	Pemeirexed pharmacokinetics and phar-macodynamics in a phase l/II study of doublet chemotherapy with vi-norelbine : implications for further optimisation of pemetrexed schedules显示文摘	Li KM Rivory LP CJarke SJ	2007	BrJ Cancer2007，97，8：	1
17	Kinetics of the in vivo inter-conversion of the carboxylatee and lactone forms of irinoteacan (CPT-11) and of its metabohte SN-38 in patients显示文摘	Rivory LP Chatelut E Canal P	1994	Cancer Res1994，54，24：	1
18	Identification and prop- erties of a major plasma metabolite of irinotecan (CPT-11) iso- lated from the plasma of patients显示文摘	Rivory LP Riou JF Haaz MC	1996	Cancer Res1996，56，16：	1
19	Clinical pharmacokinetics of docetaxel 显示文摘	Clarke SJ Rivory LP	1999	Clin Pharmacokinet1999，36，2：	1
20	Clinical pharmacokinetics of docetaxel显示文摘	Clarke S J Rivory LP	1999	ClinPharmacokinet1999，36，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示